Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing ...

The EvoLVcell stable producer cell line generation platform reportedly reduces variability and produces fewer impurities.

Throughout this three-part webinar series, experts from USP and industry will share first-hand experiences, case studies, and ...

Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability. San Sebastián, Spain, May ...

Andelyn Biosciences, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced it has received full certification under the Initiative for ...

The design of short LAM-PCR amplicons that do not exceed several hundred base pairs is critical for the efficiency of each analysis. Amplicons should be long enough to be resolved by electropheresis ...

T and gene therapies, ProBio Inc. and Curocell have achieved a significant milestone with the BLA regulatory approval and commercial readiness of Anbalcabtagene autoleucel (Anbal-cel; code: CRC01).

Orphan Therapeutics Accelerator (OTXL) , a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC Biologics, a ...

Collaboration brings AGC Biologics' advanced therapy expertise and global footprint to OTXL's network, supporting a sustainable path from clinical development to commercial access for therapies servin ...

BACKGROUND: Pulmonary hypertension (PH) is a serious complication of heart failure with preserved ejection fraction (HFpEF), ...